Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Chiorazzi

Showing results (11-20 of 167) with videos related to

Pageof 17
Sort By:
The New England Journal of Medicine|May 2, 2003
Determining the clinical course and outcome in chronic lymphocytic leukemiaKanti R Rai, Nicholas Chiorazzi
Cell Research|November 14, 2012
Chronic lymphocytic leukemia: a tale of one or two signals?Nicholas Chiorazzi, Dimitar G Efremov
Seminars in Cancer Biology|December 7, 2010
Where is the biology of CLL leading us?Federico Caligaris-Cappio, Nicholas Chiorazzi
Seminars in Hematology|July 23, 2014
Murine genetically engineered and human xenograft models of chronic lymphocytic leukemiaShih-Shih Chen, Nicholas Chiorazzi
Hematological Oncology|June 9, 2023
Functional consequences of inhibition of Bruton's tyrosine kinase by ibrutinib in chronic lymphocytic leukemiaShih-Shih Chen, Nicholas Chiorazzi
Trends in Immunology|August 10, 2013
B cell receptor signaling in chronic lymphocytic leukemiaJan A Burger, Nicholas Chiorazzi
Annals of the New York Academy of Sciences|February 8, 2006
B-cell chronic lymphocytic leukemia, a clonal disease of B lymphocytes with receptors that vary in specificity for (auto)antigensNicholas Chiorazzi, Katerina Hatzi, Emilia Albesiano
International Immunology|March 29, 2003
The global transcriptional maturation program and stimuli-specific gene expression profiles of human myeloid dendritic cellsDavorka Messmer, Bradley Messmer, Nicholas Chiorazzi
Frontiers in Oncology|May 27, 2021
AID in Chronic Lymphocytic Leukemia: Induction and Action During Disease ProgressionPablo Oppezzo, Marcelo Navarrete, Nicholas Chiorazzi
The New England Journal of Medicine|February 25, 2005
Chronic lymphocytic leukemiaNicholas Chiorazzi, Kanti R Rai, Manlio Ferrarini
Pageof 17

Showing results (11-20 of 167) with videos related to

Sort By:
Pageof 17
The New England Journal of Medicine|May 2, 2003
Determining the clinical course and outcome in chronic lymphocytic leukemiaKanti R Rai, Nicholas Chiorazzi
Cell Research|November 14, 2012
Chronic lymphocytic leukemia: a tale of one or two signals?Nicholas Chiorazzi, Dimitar G Efremov
Seminars in Cancer Biology|December 7, 2010
Where is the biology of CLL leading us?Federico Caligaris-Cappio, Nicholas Chiorazzi
Seminars in Hematology|July 23, 2014
Murine genetically engineered and human xenograft models of chronic lymphocytic leukemiaShih-Shih Chen, Nicholas Chiorazzi
Hematological Oncology|June 9, 2023
Functional consequences of inhibition of Bruton's tyrosine kinase by ibrutinib in chronic lymphocytic leukemiaShih-Shih Chen, Nicholas Chiorazzi
Trends in Immunology|August 10, 2013
B cell receptor signaling in chronic lymphocytic leukemiaJan A Burger, Nicholas Chiorazzi
Annals of the New York Academy of Sciences|February 8, 2006
B-cell chronic lymphocytic leukemia, a clonal disease of B lymphocytes with receptors that vary in specificity for (auto)antigensNicholas Chiorazzi, Katerina Hatzi, Emilia Albesiano
International Immunology|March 29, 2003
The global transcriptional maturation program and stimuli-specific gene expression profiles of human myeloid dendritic cellsDavorka Messmer, Bradley Messmer, Nicholas Chiorazzi
Frontiers in Oncology|May 27, 2021
AID in Chronic Lymphocytic Leukemia: Induction and Action During Disease ProgressionPablo Oppezzo, Marcelo Navarrete, Nicholas Chiorazzi
The New England Journal of Medicine|February 25, 2005
Chronic lymphocytic leukemiaNicholas Chiorazzi, Kanti R Rai, Manlio Ferrarini
Pageof 17